New Delhi [India], March 19: Qure.ai, a global leader in artificial intelligence (AI) for healthcare, today announced the launch of India's first AI-led Incidental Pulmonary Nodule (IPN) Detection Clinic at Thangam Cancer Centre in Namakkal, Tamil Nadu.
New research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that anatomic lung resections, such as lobectomy and segmentectomy, are associated with better long-term survival than wedge resection for patients with early-stage non-small cell lung cancer (NSCLC)
A long-term study of lung cancer in Israel released on Wednesday by the Health Ministry found that smoking -- both active and passive -- remains the primary risk factor.
Mumbai (Maharashtra) [India], November 22: Lung cancer remains one of the most prevalent and deadly cancers globally, with approximately 2.2 million new cases diagnosed annually, contributing to 18% of all cancer-related deaths, according to the International Agency for Research on Cancer. I
A group of researchers from the University of Cincinnati has discovered a possible novel approach to enhance the efficacy of radiation therapy and enhance the prognosis of patients with lung cancer metastasizing to the brain.
Ahmedabad (Gujarat) [India], September 25: Intas Pharmaceuticals Limited ("Intas") has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending approval of HETRONIFLY® (serplulimab, approve
Mumbai (Maharashtra) [India], August 20: Fractal (www.fractal.ai), a global provider of artificial intelligence and advanced analytics solutions to Fortune® 500 companies, today announced the appointment of Janaki Akella as an independent director to its board of directors.
For patients with locally advanced, unresectable non-small cell lung cancer (NSCLC), standard use of the more accurate intensity-modulated radiation therapy (IMRT) is recommended over the alternative 3D-conformal radiation therapy (3D-CRT).
Breast cancer survivors have a much greater chance of having secondary cancers, including endometrial and ovarian cancer for women and prostate cancer for men, according to new research based on data from almost 600,000 patients in England.
A study has created a tool for rapidly and inexpensively diagnosing sarcoidosis, a chronic inflammatory disease characterised by the formation of tiny lumps known as granulomas in the lungs and other organs.
Lung cancer is not the most frequent type of cancer, but it is by far the most deadly. Despite therapies such as surgery, radiation therapy, and chemotherapy, only about a quarter of all persons with the disease will live more than five years following diagnosis, and the World Health Organiz